Cargando…

Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients

BACKGROUND: Hemorrhagic transformation (HT) is a common complication in patients with cerebral infarction. However, its pathogenesis is poorly understood. The knowledge of factors that may increase risk for HT may help in improving the safety of thrombolytic therapy. AIM: To investigate the predicti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Ting-Ting, Wang, Gang, Wang, Xiao-Qin, Kong, Wei-Dan, Li, Xiao-Yu, Xue, Qian, Zou, Yu-An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567529/
https://www.ncbi.nlm.nih.gov/pubmed/34786389
http://dx.doi.org/10.12998/wjcc.v9.i30.9070
_version_ 1784594254192967680
author Zhong, Ting-Ting
Wang, Gang
Wang, Xiao-Qin
Kong, Wei-Dan
Li, Xiao-Yu
Xue, Qian
Zou, Yu-An
author_facet Zhong, Ting-Ting
Wang, Gang
Wang, Xiao-Qin
Kong, Wei-Dan
Li, Xiao-Yu
Xue, Qian
Zou, Yu-An
author_sort Zhong, Ting-Ting
collection PubMed
description BACKGROUND: Hemorrhagic transformation (HT) is a common complication in patients with cerebral infarction. However, its pathogenesis is poorly understood. The knowledge of factors that may increase risk for HT may help in improving the safety of thrombolytic therapy. AIM: To investigate the predictive value of serum calcium, albumin, globulin and matrix metalloproteinase-9 (MMP-9) levels for HT after intravenous thrombolysis (IVT) in patients with acute cerebral infarction. METHODS: Five hundred patients with acute cerebral infarction who received IVT with alteplase within 4.5 h after the onset of disease between January 2018 and January 2021 at our hospital were selected as the study subjects. They were divided into groups based on computed tomography scan results of the brain made within 36 h after thrombolysis. Forty patients with HT were enrolled in an observation group and 460 patients without HT were enrolled in a control group. Serum calcium, albumin, globulin and MMP-9 levels were compared between the two groups. Regression analysis was used to discuss the relationship between these indices and HT. RESULTS: The previous history of hypertension, diabetes, atrial fibrillation, cerebrovascular diseases, smoking and alcohol intake were not associated with HT after IVT in patients with acute cerebral infarction (all P > 0.05). The National Institutes of Health stroke scale (NHISS) score was associated with HT after IVT in patients with acute cerebral infarction (P < 0.05). The serum calcium and albumin levels were lower in the observation group than in the control group (all P < 0.05). The levels of globulin and MMP-9 were significantly higher in the observation group than in the control group (all P < 0.05). Logistic regression analysis showed that NHISS score, serum calcium, albumin, globulins and MMP-9 were independent factors influencing the occurrence of HT following IVT in patients with cerebral infarction (P < 0.05). CONCLUSION: Serum calcium, albumin, globulin and MMP-9 levels are risk factors for HT after IVT in patients with acute cerebral infarction. Moreover, NHISS score can be used as a predictor of post-thrombolytic HT.
format Online
Article
Text
id pubmed-8567529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-85675292021-11-15 Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients Zhong, Ting-Ting Wang, Gang Wang, Xiao-Qin Kong, Wei-Dan Li, Xiao-Yu Xue, Qian Zou, Yu-An World J Clin Cases Observational Study BACKGROUND: Hemorrhagic transformation (HT) is a common complication in patients with cerebral infarction. However, its pathogenesis is poorly understood. The knowledge of factors that may increase risk for HT may help in improving the safety of thrombolytic therapy. AIM: To investigate the predictive value of serum calcium, albumin, globulin and matrix metalloproteinase-9 (MMP-9) levels for HT after intravenous thrombolysis (IVT) in patients with acute cerebral infarction. METHODS: Five hundred patients with acute cerebral infarction who received IVT with alteplase within 4.5 h after the onset of disease between January 2018 and January 2021 at our hospital were selected as the study subjects. They were divided into groups based on computed tomography scan results of the brain made within 36 h after thrombolysis. Forty patients with HT were enrolled in an observation group and 460 patients without HT were enrolled in a control group. Serum calcium, albumin, globulin and MMP-9 levels were compared between the two groups. Regression analysis was used to discuss the relationship between these indices and HT. RESULTS: The previous history of hypertension, diabetes, atrial fibrillation, cerebrovascular diseases, smoking and alcohol intake were not associated with HT after IVT in patients with acute cerebral infarction (all P > 0.05). The National Institutes of Health stroke scale (NHISS) score was associated with HT after IVT in patients with acute cerebral infarction (P < 0.05). The serum calcium and albumin levels were lower in the observation group than in the control group (all P < 0.05). The levels of globulin and MMP-9 were significantly higher in the observation group than in the control group (all P < 0.05). Logistic regression analysis showed that NHISS score, serum calcium, albumin, globulins and MMP-9 were independent factors influencing the occurrence of HT following IVT in patients with cerebral infarction (P < 0.05). CONCLUSION: Serum calcium, albumin, globulin and MMP-9 levels are risk factors for HT after IVT in patients with acute cerebral infarction. Moreover, NHISS score can be used as a predictor of post-thrombolytic HT. Baishideng Publishing Group Inc 2021-10-26 2021-10-26 /pmc/articles/PMC8567529/ /pubmed/34786389 http://dx.doi.org/10.12998/wjcc.v9.i30.9070 Text en ©The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Observational Study
Zhong, Ting-Ting
Wang, Gang
Wang, Xiao-Qin
Kong, Wei-Dan
Li, Xiao-Yu
Xue, Qian
Zou, Yu-An
Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
title Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
title_full Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
title_fullStr Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
title_full_unstemmed Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
title_short Serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
title_sort serum calcium, albumin, globulin and matrix metalloproteinase-9 levels in acute cerebral infarction patients
topic Observational Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567529/
https://www.ncbi.nlm.nih.gov/pubmed/34786389
http://dx.doi.org/10.12998/wjcc.v9.i30.9070
work_keys_str_mv AT zhongtingting serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients
AT wanggang serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients
AT wangxiaoqin serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients
AT kongweidan serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients
AT lixiaoyu serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients
AT xueqian serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients
AT zouyuan serumcalciumalbuminglobulinandmatrixmetalloproteinase9levelsinacutecerebralinfarctionpatients